|
By Tom Crosby, RESI Conference Manager, LSN
With the first West Coast RESI right around the corner, we're pleased to announce the remaining five investor panels: Corporate Venture Capital, Emerging Market Investors, Medical Device Strategics, Orphan & Rare Disease Investors, and Clinical Phase I & Phase II. LSN is thrilled both with the world-class speakers and the content that they will be delivering to a record RESI audience of 500+ on January 13th. If you have yet to take a look at the first West Coast RESI's panels, they're now all available online. We hope that you'll be taking in some of this fantastic content along with us next week - if not, look for the recap videos shortly following the conference, and we'll see you at the next RESI!
Panel Announcement #1: Corporate Venture Capital
Moderated by Graeme Martin, President & CEO of Takeda Ventures the audience will hear from:
- Priyanka Rohatgi, Director, Baxter Ventures
- Tetsuro Iwata, Senior Manager, MP Healthcare Venture Management
- Barbara Dalton, Vice President, Pfizer Venture Investments
- Jason Hafler, Director of Investments, Sanofi-Genzyme BioVentures
- Sofie Qiao, Managing Director, WuXi Venture Fund
Panel Announcement #2: Emerging Market Investors
Moderated by Pushpa Vijayaraghavan, Vice President of Sathguru the audience will hear from: ...
| 
Life Science Investor Mandates 
